Skip to main content
Top

09-05-2024 | Obesity

Stopgap Measures for Obesity Prior to Surgery

Authors: Nagesh Kamat, Amit Maydeo, Gaurav Patil, Ankit Dalal, Amol Vadgaonkar, Sanil Parekh

Published in: Current Gastroenterology Reports

Login to get access

Abstract

Purpose of Review

The data on preventive measures for managing obesity prior to surgery is limited. This review highlights the role of stopgap measures for managing obesity before surgery.

Recent Findings

Body weight regulation to achieve sustainable weight loss is a gradual process. Regular aerobic exercises, transformative yoga and restrained eating can contribute to a calorie deficit. Behavioural strategies aim to raise awareness, set goals, manage stress, and support adherence to healthier lifestyles. Pharmacotherapy can be adjunctive in inducing weight loss but could be better at maintaining weight. Intragastric balloon and endoscopic sleeve gastroplasty are restrictive procedures for patients before surgery.

Summary

Obesity is a multifaceted chronic disease with adverse health consequences. There is a need to identify contributors to weight gain and treatment should target the cause of obesity. Utilize stop-gap measures and monitor progress for step-up or more intensive treatment. Structured weight loss needs lifelong commitment.
Literature
2.
go back to reference Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10(5):351–65.CrossRefPubMedPubMedCentral Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10(5):351–65.CrossRefPubMedPubMedCentral
3.
go back to reference Sivasubramanian R, Malhotra S. Genetic contributors to obesity. Gastroenterol Clin North Am. 2023;52(2):323–32.CrossRefPubMed Sivasubramanian R, Malhotra S. Genetic contributors to obesity. Gastroenterol Clin North Am. 2023;52(2):323–32.CrossRefPubMed
4.
go back to reference Koliaki C, Liatis S, Dalamaga M, Kokkinos A. The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obes Rep. 2020;9(3):255–71.CrossRefPubMed Koliaki C, Liatis S, Dalamaga M, Kokkinos A. The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obes Rep. 2020;9(3):255–71.CrossRefPubMed
5.
go back to reference Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15(4):226–37.CrossRefPubMed Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15(4):226–37.CrossRefPubMed
6.
go back to reference Wewege MA, Desai I, Honey C, et al. The effect of resistance training in healthy adults on body fat percentage, fat mass and visceral fat: a systematic review and meta-analysis. Sports Med. 2022;52(2):287–300.CrossRefPubMed Wewege MA, Desai I, Honey C, et al. The effect of resistance training in healthy adults on body fat percentage, fat mass and visceral fat: a systematic review and meta-analysis. Sports Med. 2022;52(2):287–300.CrossRefPubMed
8.
go back to reference Chang JJ, Bena J, Kannan S, et al. Limited carbohydrate refeeding instruction for long-term weight maintenance following a ketogenic, very-low-calorie meal plan. Endocr Pract. 2017;23(6):649–56.CrossRefPubMed Chang JJ, Bena J, Kannan S, et al. Limited carbohydrate refeeding instruction for long-term weight maintenance following a ketogenic, very-low-calorie meal plan. Endocr Pract. 2017;23(6):649–56.CrossRefPubMed
9.
go back to reference Grunvald E, Shah R, Hernaez R, AGA Clinical Guidelines Committee, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198–225.CrossRefPubMed Grunvald E, Shah R, Hernaez R, AGA Clinical Guidelines Committee, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198–225.CrossRefPubMed
10.
go back to reference Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2022;399(10321):259–69.CrossRefPubMed Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2022;399(10321):259–69.CrossRefPubMed
11.
go back to reference Shah R, Davitkov P, Abu Dayyeh BK, et al. AGA technical review on intragastric balloons in the management of obesity. Gastroenterology. 2021;160(5):1811–30.CrossRefPubMed Shah R, Davitkov P, Abu Dayyeh BK, et al. AGA technical review on intragastric balloons in the management of obesity. Gastroenterology. 2021;160(5):1811–30.CrossRefPubMed
12.
go back to reference Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30(7):2743–53.CrossRefPubMed Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30(7):2743–53.CrossRefPubMed
13.
go back to reference •• Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441–51. (A multi-center randomized trial proving effectiveness of ESG for obesity)CrossRefPubMed •• Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441–51. (A multi-center randomized trial proving effectiveness of ESG for obesity)CrossRefPubMed
14.
go back to reference Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg. 2020;30(8):3010–29.CrossRefPubMedPubMedCentral Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg. 2020;30(8):3010–29.CrossRefPubMedPubMedCentral
15.
go back to reference • Sharaiha RZ, Shikora S, White KP, et al. Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol. 2023;57(10):967–76. (A comprehensive guideline in the management of obesity)CrossRefPubMedPubMedCentral • Sharaiha RZ, Shikora S, White KP, et al. Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO). J Clin Gastroenterol. 2023;57(10):967–76. (A comprehensive guideline in the management of obesity)CrossRefPubMedPubMedCentral
16.
go back to reference Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev. 2012;13(6):509–17.CrossRefPubMed Middleton KM, Patidar SM, Perri MG. The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev. 2012;13(6):509–17.CrossRefPubMed
Metadata
Title
Stopgap Measures for Obesity Prior to Surgery
Authors
Nagesh Kamat
Amit Maydeo
Gaurav Patil
Ankit Dalal
Amol Vadgaonkar
Sanil Parekh
Publication date
09-05-2024
Publisher
Springer US
Keywords
Obesity
Obesity
Published in
Current Gastroenterology Reports
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-024-00933-9
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare